2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now

The market has discounted a fair number of stocks over the last few years, and some for good reason. At the same time, share price alone tells you relatively little other than what the broader market seems to think the stock is worth at that given moment in time. A stock can easily be overvalued or undervalued, and it's important to understand the drivers behind the stock's performance before you decide whether it's a good fit for your portfolio.If you're looking for quality businesses trading on sale, there are plenty of contenders to consider. Here are two such magnificent growth stocks that you can buy at a discount right now.DexCom (NASDAQ: DXCM) is known for its range of continuous glucose monitoring (CGM) devices, which enable diabetics and even pre-diabetics to track blood sugar levels to mitigate adverse events. Investors have been particularly hard on this stock recently, driving shares down by approximately 45% from the beginning of 2024. A stock trading on sale should never be the main reason to buy or sell shares, and it's important to probe deeper to determine what factors are moving the needle.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool